Connection

Co-Authors

This is a "connection" page, showing publications co-authored by MARY ESTES and MARGARET CONNER.
Connection Strength

2.005
  1. A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U S A. 2017 01 24; 114(4):E570-E579.
    View in: PubMed
    Score: 0.144
  2. Virus-like particle vaccines for mucosal immunization. Adv Exp Med Biol. 1997; 412:387-95.
    View in: PubMed
    Score: 0.144
  3. Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits. Arch Virol. 1997; 142(11):2281-94.
    View in: PubMed
    Score: 0.144
  4. Virus-like particles as a rotavirus subunit vaccine. J Infect Dis. 1996 Sep; 174 Suppl 1:S88-92.
    View in: PubMed
    Score: 0.141
  5. Rotavirus subunit vaccines. Arch Virol Suppl. 1996; 12:199-206.
    View in: PubMed
    Score: 0.134
  6. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol. 2016 01 01; 90(1):43-56.
    View in: PubMed
    Score: 0.132
  7. Rotavirus vaccines and vaccination potential. Curr Top Microbiol Immunol. 1994; 185:285-337.
    View in: PubMed
    Score: 0.117
  8. Rotavirus vaccine administered parenterally induces protective immunity. J Virol. 1993 Nov; 67(11):6633-41.
    View in: PubMed
    Score: 0.116
  9. Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity. J Virol. 2008 Mar; 82(6):3135-8.
    View in: PubMed
    Score: 0.077
  10. Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol. 2006 May; 80(10):4820-32.
    View in: PubMed
    Score: 0.069
  11. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine. 2006 Feb 20; 24(8):1170-9.
    View in: PubMed
    Score: 0.066
  12. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol. 2004 Jul; 78(13):6974-81.
    View in: PubMed
    Score: 0.060
  13. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine. 2003 Sep 08; 21(25-26):3885-900.
    View in: PubMed
    Score: 0.057
  14. Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J Virol. 2002 Jan; 76(1):41-57.
    View in: PubMed
    Score: 0.051
  15. Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal transmission in rabbits. J Gen Virol. 2000 May; 81(Pt 5):1237-49.
    View in: PubMed
    Score: 0.045
  16. Species specificity and interspecies relatedness of NSP4 genetic groups by comparative NSP4 sequence analyses of animal rotaviruses. Arch Virol. 2000; 145(2):371-83.
    View in: PubMed
    Score: 0.044
  17. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol. 1999 Jun; 73(6):4813-22.
    View in: PubMed
    Score: 0.043
  18. Rotavirus disease, but not infection and development of intestinal histopathological lesions, is age restricted in rabbits. Virology. 1998 Nov 25; 251(2):343-60.
    View in: PubMed
    Score: 0.041
  19. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol. 1998 Nov; 72(11):9233-46.
    View in: PubMed
    Score: 0.041
  20. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J Virol. 1998 Apr; 72(4):3390-3.
    View in: PubMed
    Score: 0.039
  21. Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections. J Virol. 1998 Mar; 72(3):2341-51.
    View in: PubMed
    Score: 0.039
  22. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol. 1998 Feb; 72(2):1345-53.
    View in: PubMed
    Score: 0.039
  23. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol. 1997 Nov; 71(11):8707-17.
    View in: PubMed
    Score: 0.038
  24. Comparative amino acid sequence analysis of the outer capsid protein VP4 from four lapine rotavirus strains reveals identity with genotype P[14] human rotaviruses. Arch Virol. 1997; 142(5):1059-69.
    View in: PubMed
    Score: 0.036
  25. Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr. 1992 Jun; 120(6):912-7.
    View in: PubMed
    Score: 0.026
  26. Serologic and mucosal immune response to rotavirus infection in the rabbit model. J Virol. 1991 May; 65(5):2562-71.
    View in: PubMed
    Score: 0.024
  27. Molecular biology and immunology of rotavirus infections. Immunol Invest. 1989 Jan-May; 18(1-4):571-81.
    View in: PubMed
    Score: 0.021
  28. Rabbit model of rotavirus infection. J Virol. 1988 May; 62(5):1625-33.
    View in: PubMed
    Score: 0.020
  29. Molecular characterization of three rabbit rotavirus strains. Arch Virol. 1988; 98(3-4):253-65.
    View in: PubMed
    Score: 0.019
  30. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun. 2005 May; 73(5):2999-3006.
    View in: PubMed
    Score: 0.016
  31. Rotavirus antigenaemia and viraemia: a common event? Lancet. 2003 Nov 01; 362(9394):1445-9.
    View in: PubMed
    Score: 0.014
  32. Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol Suppl. 1996; 12:243-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.